354 related articles for article (PubMed ID: 32169537)
21. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation.
Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887
[TBL] [Abstract][Full Text] [Related]
22. Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein.
Taharabaru T; Yokoyama R; Higashi T; Mohammed AFA; Inoue M; Maeda Y; Niidome T; Onodera R; Motoyama K
ACS Appl Mater Interfaces; 2020 May; 12(19):21386-21397. PubMed ID: 32315156
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
24. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
Dhokane D; Bhadra B; Dasgupta S
Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
[TBL] [Abstract][Full Text] [Related]
25. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes.
Staahl BT; Benekareddy M; Coulon-Bainier C; Banfal AA; Floor SN; Sabo JK; Urnes C; Munares GA; Ghosh A; Doudna JA
Nat Biotechnol; 2017 May; 35(5):431-434. PubMed ID: 28191903
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
27. A Rationally Designed Semiconducting Polymer Brush for NIR-II Imaging-Guided Light-Triggered Remote Control of CRISPR/Cas9 Genome Editing.
Li L; Yang Z; Zhu S; He L; Fan W; Tang W; Zou J; Shen Z; Zhang M; Tang L; Dai Y; Niu G; Hu S; Chen X
Adv Mater; 2019 May; 31(21):e1901187. PubMed ID: 30957918
[TBL] [Abstract][Full Text] [Related]
28. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.
Mun D; Kang JY; Kim H; Yun N; Joung B
J Control Release; 2024 May; ():. PubMed ID: 38754633
[TBL] [Abstract][Full Text] [Related]
29. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.
Chen G; Abdeen AA; Wang Y; Shahi PK; Robertson S; Xie R; Suzuki M; Pattnaik BR; Saha K; Gong S
Nat Nanotechnol; 2019 Oct; 14(10):974-980. PubMed ID: 31501532
[TBL] [Abstract][Full Text] [Related]
30. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
31. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
32. Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption.
Ha JS; Lee JS; Jeong J; Kim H; Byun J; Kim SA; Lee HJ; Chung HS; Lee JB; Ahn DR
J Control Release; 2017 Mar; 250():27-35. PubMed ID: 28167287
[TBL] [Abstract][Full Text] [Related]
33. Microneedle-assisted genome editing: A transdermal strategy of targeting
Wan T; Pan Q; Ping Y
Sci Adv; 2021 Mar; 7(11):. PubMed ID: 33692106
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
35. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
36. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
[TBL] [Abstract][Full Text] [Related]
37. Phenylboronic acid-functionalized polyaminoglycoside as an effective CRISPR/Cas9 delivery system.
Shao M; Qi Y; Sui D; Xu FJ
Biomater Sci; 2021 Oct; 9(21):7104-7114. PubMed ID: 34704559
[TBL] [Abstract][Full Text] [Related]
38. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
[TBL] [Abstract][Full Text] [Related]
39. Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing
Hamada T; Yokoyama S; Akahane T; Matsuo K; Tanimoto A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613947
[TBL] [Abstract][Full Text] [Related]
40. Editing the genome of Aphanomyces invadans using CRISPR/Cas9.
Majeed M; Soliman H; Kumar G; El-Matbouli M; Saleh M
Parasit Vectors; 2018 Oct; 11(1):554. PubMed ID: 30352624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
